Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India
Tila Khan,
No information about this author
Ranjan Das,
No information about this author
Mithu Jana
No information about this author
et al.
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: July 31, 2024
Influenza,
COVID-19,
tetanus,
pertussis
and
hepatitis
B
pose
increased
risk
for
pregnant
women
infants
could
be
mitigated
by
maternal
immunization.
In
India
Tetanus-diphtheria
(Td)
COVID-19
vaccines
are
recommended
during
pregnancy,
while
influenza
tetanus-acellular
pertussis-diphtheria
(Tdap)
not.
We
conducted
a
multicenter
study
from
November
2021
to
June
2022
among
(n
=
172)
attending
antenatal
clinics
in
three
public
hospitals
West
Bengal,
understand
the
factors
that
influence
women's
decisions
get
vaccinated
pregnancy.
Questions
assessed
vaccination
coverage,
knowledge,
intention
willingness
pay
vaccine,
influencing
Td,
influenza,
vaccines.
152/172
(88.4%)
were
with
159/172
(93%)
1/172
(0.6%)
none
Tdap.
10/168
(6%)
had
received
vaccine
(HBV).
Community
health
workers
advice
was
crucial
Td
uptake
and,
belief
of
protection
COVID
Most
unaware
about
Tdap
(96%),
(75%),
severity
pregnancy
infancy
(85%).
None
advised
healthcare
providers
(HCP),
albeit,
93%
expressed
take,
INR
100-300
(95%
CI:
≤100
300-500)
[$
1.3-4.0
≤1.3,
4-6.7)]
it.
Vaccination
on
flexible
dates
time,
HCP's
recommendation,
proximity
center,
husband's
support
most
important
their
decisions.
Women
generally
acceptors
high
included
Universal
Immunization
Program
(UIP).
Inclusion
Tdap,
HBV
into
UIP
may
improve
uptake.
Language: Английский
Effect of the COVID-19 vaccination on feto-maternal outcomes: A prospective cohort study among Indian pregnant women
Aravind P. Gandhi,
No information about this author
JS Thakur,
No information about this author
Madhu Gupta
No information about this author
et al.
The Indian Journal of Medical Research,
Journal Year:
2024,
Volume and Issue:
160, P. 371 - 378
Published: Nov. 15, 2024
Background
&
objectives
Studies
on
the
effects
of
COVID-19
vaccination
among
pregnant
women
in
Asian
settings,
more
specifically
India,
are
scarce.
The
present
study
evaluated
feto-maternal
outcomes
Indian
who
received
vaccine.
Methods
A
prospective
cohort
was
undertaken
430
from
two
primary
health
centres
(PHC)
Chandigarh,
India
during
2021-2022.
included
abortions,
live
birth/stillbirth,
term/pre-term/post-term
delivery,
mode
delivery
(normal
vaginal/caesarean
section/forceps),
birth
weight
and
intrauterine
growth
retardation.
Results
Of
participants,
295
vaccines,
with
an
uptake
rate
68.6
per
cent.
Majority
vaccinated
(280-
completed
study)
were
their
second
trimester
(133,
47.5%),
while
92
(32.9%)
third,
55
(19.6%)
first
when
they
enrolled
study.
Neonatal
intensive
care
unit
(NICU)
admission
significantly
lower
women,
other
neonatal
similar
between
unvaccinated
women.
Interpretation
conclusions
findings
this
suggest
might
be
safe,
terms
Language: Английский